Research and Development

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities.  Juserius who …

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …

Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and …

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …

Synthetic Biologics has appointed Carol Reed as senior vice president of Clinical & Regulatory Affairs. In this position Reed will …